GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SC Ropharma SA (BSE:RPH) » Definitions » Debt-to-Revenue

SC Ropharma (BSE:RPH) Debt-to-Revenue : 0.15 (As of Jun. 2024)


View and export this data going back to 1997. Start your Free Trial

What is SC Ropharma Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

SC Ropharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was lei64 Mil. SC Ropharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was lei102 Mil. SC Ropharma's annualized Revenue for the quarter that ended in Jun. 2024 was lei1,121 Mil. SC Ropharma's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 was 0.15.


SC Ropharma Debt-to-Revenue Historical Data

The historical data trend for SC Ropharma's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SC Ropharma Debt-to-Revenue Chart

SC Ropharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.20 0.18 0.16 0.16

SC Ropharma Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.16 0.14 0.16 0.15

Competitive Comparison of SC Ropharma's Debt-to-Revenue

For the Pharmaceutical Retailers subindustry, SC Ropharma's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SC Ropharma's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SC Ropharma's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where SC Ropharma's Debt-to-Revenue falls into.



SC Ropharma Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

SC Ropharma's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(64.27 + 99.81) / 1009.627
=0.16

SC Ropharma's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(64.087 + 101.946) / 1121.022
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2024) Revenue data.


SC Ropharma Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of SC Ropharma's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SC Ropharma Business Description

Traded in Other Exchanges
N/A
Address
Strada Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.

SC Ropharma Headlines

No Headlines